Literature DB >> 6520685

Biobrane--a useful adjunct in the therapy of outpatient burns.

R L Klein, B F Rothmann, R Marshall.   

Abstract

Fifty-five patients with partial thickness burns ranging from 1% to 10% of their body surfaces have been treated with Biobrane (Woodroof Laboratories, Santa Ana, CA) dressings on an outpatient basis. This material is a biosynthetic skin prosthesis that was introduced commercially in 1979. Advantages of Biobrane over other conventional dressings in outpatient burn care have been the significant pain relief, reduced number of dressing changes, decreased patient visits, and satisfactory epithelization in 7 to 14 days, ease of application and removal, and cost effectiveness. The dressing must be placed on clean wounds judged to be partial thickness in depth. Topical antibiotics are unnecessary in the care of these patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520685     DOI: 10.1016/s0022-3468(84)80382-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

Review 1.  Paediatric partial-thickness scald burns--is Biobrane the best treatment available?

Authors:  Anirban Mandal
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

2.  Effectiveness of Biobrane for treatment of partial-thickness burns in children.

Authors:  Aaron P Lesher; Ryan H Curry; Jill Evans; Valerie A Smith; Michael T Fitzgerald; Robert A Cina; Christian J Streck; Andre V Hebra
Journal:  J Pediatr Surg       Date:  2011-09       Impact factor: 2.545

Review 3.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

4.  Reduction in wound bioburden using a silver-loaded dissolvable microfilm construct.

Authors:  Maggie Herron; Ankit Agarwal; Patricia R Kierski; Diego F Calderon; Leandro B C Teixeira; Michael J Schurr; Christopher J Murphy; Charles J Czuprynski; Jonathan F McAnulty; Nicholas L Abbott
Journal:  Adv Healthc Mater       Date:  2014-02-12       Impact factor: 9.933

5.  A Clinical Study Comparing Helicoll with Scarlet Red and OpSite in the Treatment of Split Thickness Skin Graft Donor Sites-A Randomized Controlled Trial.

Authors:  Prema Dhanraj
Journal:  Indian J Surg       Date:  2013-02-21       Impact factor: 0.656

Review 6.  Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.

Authors:  Krishna S Vyas; Henry C Vasconez
Journal:  Healthcare (Basel)       Date:  2014-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.